Carlyle in $3.8bn vitamin take-private
The firm is paying a 57% premium over NYSE-listed NBTY’s recent average closing price.
Home Private Equity News & Analysis Private Equity Deals & Transactions Carlyle in $3.8bn vitamin take-private
The firm is paying a 57% premium over NYSE-listed NBTY’s recent average closing price.
Copyright PEI Media
Not for publication, email or dissemination